文献速递湿疹皮炎与荨麻疹

胶带粘贴法检测早发性特应性皮炎患儿皮肤免疫与屏障异常

Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis.
PubMed 文献 · JAMA Dermatol · 2019-01-01

这项横断面研究纳入51名5岁以下儿童,其中21例中重度特应性皮炎(AD)患儿病程不足6个月,30名无AD儿童。

要点

  • 胶带粘贴法在儿童中可检测97%的免疫和屏障基因产物,样本检出率99%。
  • 53个标记物可区分AD患儿与无AD儿童,包括T细胞、树突状细胞及TH2/TH17/TH22相关基因。
  • 皮损和非皮损区IL-4等炎症基因升高,FLG等屏障基因降低,且与疾病严重程度相关。

核心结论

  • 胶带粘贴法为连续评估儿童AD皮肤生物标志物提供了微创替代方法,可能有助于追踪治疗反应和预测疾病进程。

研究设计与样本

  • 横断面研究,纳入51名5岁以下儿童,21例中重度AD(病程<6个月)和30名无AD儿童,于2016年1月22日至2018年4月20日从皮肤科门诊招募。

主要发现

  • 53个标记物能区分AD患儿(皮损和/或非皮损)与无AD儿童。
  • 皮损和非皮损AD中T细胞(CD3)、AD相关树突状细胞(FcεRI和OX40配体受体)、炎症(MMP12)、先天免疫(IL-8和IL-6)、TH2(IL-4、IL-13、CCL17、CCL26)和TH17/TH22(IL-19、IL-36G、S100A蛋白)基因显著升高。
  • 表皮屏障基因产物(FLG、CLDN23、FA2H)和负性免疫调节因子(IL-34、IL-37)平行降低。
  • 疾病严重程度或经皮水分丢失与皮损和非皮损AD皮肤中TH2(IL-33、IL-4R)和TH17/TH22(IL-36G、S100As)产物相关。

关键数值与推荐

  • IL-4均值(SE):皮损-15.2(0.91),正常-19.5(0.48);P<.001。
  • FLG均值(SE):皮损-2.9(0.42),正常2.2(0.45);P<.001。

临床怎么用

  • 胶带粘贴法可作为儿童AD皮肤生物标志物的微创连续监测工具,用于评估治疗反应和预测疾病进程。

局限性

  • 横断面设计,样本量较小(51例),仅纳入5岁以下儿童,未报告长期随访结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Molecular profiling of skin biopsies is the criterion standard for evaluating the cutaneous atopic dermatitis (AD) phenotype. However, skin biopsies are not always feasible in children. A reproducible minimally invasive approach that can track cutaneous disease in pediatric longitudinal studies or clinical trials is lacking. OBJECTIVE: To assess a minimally invasive approach using tape strips to identify skin biomarkers that may serve as a surrogate to biomarkers identified using whole-tissue biopsies. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study of 51 children younger than 5 years recruited children with moderate to severe AD and children without AD from the dermatology outpatient clinics at a children's hospital. Sixteen tape strips were serially collected from the nonlesional and lesional skin of 21 children who had AD and were less than 6 months from disease initiation and from the normal skin of 30 children who did not have AD between January 22, 2016, and April 20, 2018. MAIN OUTCOMES AND MEASURES: Gene and protein expression were evaluated using quantitative real-time polymerase chain reaction and immunohistochemistry. RESULTS: A total of 51 children younger than 5 years were included in the study; 21 children had moderate to severe AD with less than 6 months of disease duration, and 30 children did not have AD. Of the 21 children with AD, the mean (SD) age was 1.7 (1.7) years, and most were male (15 [71.4%] and white (15 [71.4%]). Of the 30 children without AD, the mean (SD) age was 1.8 (2.0) years, and most were female (20 [66.7%]) and white (22 [73.3%]). Seventy-seven of 79 evaluated immune and barrier gene products were detected (gene detection rate, 97%) in 70 of 71 tape strips (sample detection rate, 99%), with 53 of 79 markers differentiating between children with lesional and/or nonlesional AD from children without AD. Many cellular markers of T cells (CD3), AD-related dendritic cells (Fc ε RI and OX40 ligand receptors), and key inflammatory (matrix metallopeptidase 12), innate (interleukin 8 [IL-8] and IL-6), helper T cell 2 (TH2; IL-4, IL-13, and chemokines CCL17 and CCL26), and TH17/TH22 (IL-19, IL-36G, and S100A proteins) genes were significantly increased in lesional and nonlesional AD compared with tape strips from normal skin. For example, IL-4 mean (SE) for lesional was -15.2 (0.91) and normal was -19.5 (0.48); P < .001. Parallel decreases occurred in epidermal barrier gene products (FLG, CLDN23, and FA2H) and negative immune regulators (IL-34 and IL-37). For example, the decrease for FLG lesional was mean (SE) -2.9 (0.42) and for normal was 2.2 (0.45); P < .001. Associations were found between disease severity or transepidermal water loss and TH2 (IL-33 and IL-4R) and TH17/TH22 (IL-36G and S100As) products in lesional and nonlesional AD skin (evaluated using the SCORing Atopic Dermatitis, Eczema Area and Severity Index, and Pruritus Atopic Dermatitis Quickscore tools). CONCLUSIONS AND RELEVANCE: In this study, tape strips provide a minimally invasive alternative for serially evaluating AD-associated cutaneous biomarkers and may prove useful for tracking pediatric AD therapeutic response and predicting future course and comorbidities.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Guttman-Yassky E, Diaz A, Pavel AB, et al. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis. JAMA Dermatol. 2019. PMID: 31596431. doi:10.1001/jamadermatol.2019.2983

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。